Pulmonary syndrome and intravenous high-dose desferrioxamine

Lancet. 1990 Dec 15;336(8729):1511. doi: 10.1016/0140-6736(90)93217-d.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Child
  • Deferoxamine / administration & dosage*
  • Deferoxamine / adverse effects
  • Humans
  • Infusions, Intravenous
  • Pulmonary Fibrosis / chemically induced*
  • Thalassemia / drug therapy*

Substances

  • Deferoxamine